Detection of Titanium Particles in Human Liver and Spleen and Possible Health Implications

Overview

Journal Part Fibre Toxicol

Publisher Biomed Central

Specialty Toxicology

Date 2018 Apr 13

PMID 29642936

Citations 49

Authors

M B Heringa

R J B Peters

R L A W Bleys

M K van der Lee

P C Tromp

P C E van Kesteren

J C H van Eijkeren

A K Undas

A G Oomen

H Bouwmeester

Affiliations

Soon will be listed here.

Abstract

Background: Titanium dioxide (TiO) is produced at high volumes and applied in many consumer and food products. Recent toxicokinetic modelling indicated the potential of TiO to accumulate in human liver and spleen upon daily oral exposure, which is not routinely investigated in chronic animal studies. A health risk from nanosized TiO particle consumption could not be excluded then.

Results: Here we show the first quantification of both total titanium (Ti) and TiO particles in 15 post-mortem human livers and spleens. These low-level analyses were enabled by the use of fully validated (single particle) inductively coupled plasma high resolution mass spectrometry ((sp)ICP-HRMS) detection methods for total Ti and TiO particles. The presence of TiO in the particles in tissues was confirmed by Scanning Electron Microscopy with energy dispersive X-ray spectrometry.

Conclusions: These results prove that TiO particles are present in human liver and spleen, with ≥24% of nanosize (< 100 nm). The levels are below the doses regarded as safe in animals, but half are above the dose that is deemed safe for liver damage in humans when taking into account several commonly applied uncertainty factors. With these new and unique human data, we remain with the conclusion that health risks due to oral exposure to TiO cannot be excluded.

Citing Articles

Enhanced intestinal epithelial co-culture model with orbital mechanical stimulation: a proof-of-concept application in food nanotoxicology.

Santoni M, Piccinini G, Liguori G, Randi M, Baroncini M, Milani L Front Mol Biosci. 2025; 11:1529027.

PMID: 39872165 PMC: 11769796. DOI: 10.3389/fmolb.2024.1529027.

Nanotechnology in healthcare, and its safety and environmental risks.

Ma X, Tian Y, Yang R, Wang H, Allahou L, Chang J J Nanobiotechnology. 2024; 22(1):715.

PMID: 39548502 PMC: 11566612. DOI: 10.1186/s12951-024-02901-x.

Genome-wide DNA methylation sequencing reveals the involvement of ferroptosis in hepatotoxicity induced by dietary exposure to food-grade titanium dioxide.

Shang J, Yan J, Lou H, Shou R, Zhan Y, Lu X Part Fibre Toxicol. 2024; 21(1):37.

PMID: 39294687 PMC: 11409784. DOI: 10.1186/s12989-024-00598-2.

Enhanced Intrusion of Exogenous Airborne Fine Particles toward Eyes in Humans and Animals: Where Damaged Blood-Ocular Barrier Plays a Crucial Role.

Qi Y, Liu X, Chen Y, Wu Y, Sun Y, Liu X Environ Sci Technol. 2024; 58(31):13636-13647.

PMID: 38961559 PMC: 11308520. DOI: 10.1021/acs.est.4c01791.

Assessing the Impact of Various Decontamination Instruments on Titanium and Zirconia Dental Implants: An In Vitro Study.

Vierling L, Liu C, Wiedemeier D, Gubler A, Schmidlin P Dent J (Basel). 2024; 12(5).

PMID: 38786534 PMC: 11119916. DOI: 10.3390/dj12050136.

References

Loeschner K, Brabrand M, Sloth J, Larsen E . Use of alkaline or enzymatic sample pretreatment prior to characterization of gold nanoparticles in animal tissue by single-particle ICPMS. Anal Bioanal Chem. 2013; 406(16):3845-51. DOI: 10.1007/s00216-013-7431-y. View

Geraets L, Oomen A, Krystek P, Jacobsen N, Wallin H, Laurentie M . Tissue distribution and elimination after oral and intravenous administration of different titanium dioxide nanoparticles in rats. Part Fibre Toxicol. 2014; 11:30. PMC: 4105399. DOI: 10.1186/1743-8977-11-30. View

Kreyling W, Holzwarth U, Haberl N, Kozempel J, Wenk A, Hirn S . Quantitative biokinetics of titanium dioxide nanoparticles after intratracheal instillation in rats: Part 3. Nanotoxicology. 2017; 11(4):454-464. DOI: 10.1080/17435390.2017.1306894. View

Chaudhry Q . Opinion of the Scientific Committee on Consumer safety (SCCS) - Revision of the opinion on the safety of the use of titanium dioxide, nano form, in cosmetic products. Regul Toxicol Pharmacol. 2015; 73(2):669-70. DOI: 10.1016/j.yrtph.2015.09.005. View

Rompelberg C, Heringa M, van Donkersgoed G, Drijvers J, Roos A, Westenbrink S . Oral intake of added titanium dioxide and its nanofraction from food products, food supplements and toothpaste by the Dutch population. Nanotoxicology. 2016; 10(10):1404-1414. DOI: 10.1080/17435390.2016.1222457. View

Bettini S, Boutet-Robinet E, Cartier C, Comera C, Gaultier E, Dupuy J . Food-grade TiO impairs intestinal and systemic immune homeostasis, initiates preneoplastic lesions and promotes aberrant crypt development in the rat colon. Sci Rep. 2017; 7:40373. PMC: 5247795. DOI: 10.1038/srep40373. View

Yukawa M, Amano K, Terai M . Distribution of trace elements in the human body determined by neutron activation analysis. Arch Environ Health. 1980; 35(1):36-44. DOI: 10.1080/00039896.1980.10667459. View

Weir A, Westerhoff P, Fabricius L, Hristovski K, von Goetz N . Titanium dioxide nanoparticles in food and personal care products. Environ Sci Technol. 2012; 46(4):2242-50. PMC: 3288463. DOI: 10.1021/es204168d. View

Shi H, Magaye R, Castranova V, Zhao J . Titanium dioxide nanoparticles: a review of current toxicological data. Part Fibre Toxicol. 2013; 10:15. PMC: 3637140. DOI: 10.1186/1743-8977-10-15. View

10.

Urrutia-Ortega I, Garduno-Balderas L, Delgado-Buenrostro N, Freyre-Fonseca V, Flores-Flores J, Gonzalez-Robles A . Food-grade titanium dioxide exposure exacerbates tumor formation in colitis associated cancer model. Food Chem Toxicol. 2016; 93:20-31. DOI: 10.1016/j.fct.2016.04.014. View

11.

Bello D, Warheit D . Biokinetics of engineered nano-TiO in rats administered by different exposure routes: implications for human health. Nanotoxicology. 2017; 11(4):431-433. DOI: 10.1080/17435390.2017.1330436. View

12.

Powell J, Faria N, Thomas-McKay E, Pele L . Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract. J Autoimmun. 2010; 34(3):J226-33. DOI: 10.1016/j.jaut.2009.11.006. View

13.

Pele L, Thoree V, Bruggraber S, Koller D, Thompson R, Lomer M . Pharmaceutical/food grade titanium dioxide particles are absorbed into the bloodstream of human volunteers. Part Fibre Toxicol. 2015; 12:26. PMC: 4557898. DOI: 10.1186/s12989-015-0101-9. View

14.

Lee S, Bi X, Reed R, Ranville J, Herckes P, Westerhoff P . Nanoparticle size detection limits by single particle ICP-MS for 40 elements. Environ Sci Technol. 2014; 48(17):10291-300. DOI: 10.1021/es502422v. View

15.

Peters R, van Bemmel G, Herrera-Rivera Z, Helsper H, Marvin H, Weigel S . Characterization of titanium dioxide nanoparticles in food products: analytical methods to define nanoparticles. J Agric Food Chem. 2014; 62(27):6285-93. DOI: 10.1021/jf5011885. View

16.

Bockmann J, Lahl H, Eckert T, UNTERHALT B . [Blood titanium levels before and after oral administration titanium dioxide]. Pharmazie. 2000; 55(2):140-3. View

17.

Tassinari R, Cubadda F, Moracci G, Aureli F, DAmato M, Valeri M . Oral, short-term exposure to titanium dioxide nanoparticles in Sprague-Dawley rat: focus on reproductive and endocrine systems and spleen. Nanotoxicology. 2013; 8(6):654-62. DOI: 10.3109/17435390.2013.822114. View

18.

Laborda F, Bolea E, Jimenez-Lamana J . Single particle inductively coupled plasma mass spectrometry: a powerful tool for nanoanalysis. Anal Chem. 2013; 86(5):2270-8. DOI: 10.1021/ac402980q. View

19.

Kreyling W, Holzwarth U, Schleh C, Kozempel J, Wenk A, Haberl N . Quantitative biokinetics of titanium dioxide nanoparticles after oral application in rats: Part 2. Nanotoxicology. 2017; 11(4):443-453. DOI: 10.1080/17435390.2017.1306893. View

20.

Warheit D, Donner E . Risk assessment strategies for nanoscale and fine-sized titanium dioxide particles: Recognizing hazard and exposure issues. Food Chem Toxicol. 2015; 85:138-47. DOI: 10.1016/j.fct.2015.07.001. View